Clinical Trials Directory

Trials / Completed

CompletedNCT00399633

Neuropeptides in the Humane Intra- og Extracerebral Circulation.

Neuropeptides in the Humane Intra- og Extracerebral Circulation - in Relation to Sumatriptan in Healthy Volunteers.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.

Detailed description

The study is meant to give a better understanding of the basic mechanisms behind migraine, and a better understanding of the effects of sumatriptan on the trigemino vascular system. The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.

Conditions

Interventions

TypeNameDescription
DRUGsumatriptan

Timeline

Start date
2007-01-01
Primary completion
2007-04-01
Completion
2007-04-01
First posted
2006-11-15
Last updated
2008-05-14

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00399633. Inclusion in this directory is not an endorsement.

Neuropeptides in the Humane Intra- og Extracerebral Circulation. (NCT00399633) · Clinical Trials Directory